Diagnostic Kits/Give an overall picture of the Kits' sector
Jump to navigation
Jump to search
Many of these questions can be answered from data in the The Value of Diagnostics report (caution: sponsored by AdvaMed), starting with the Profile of the Diagnostics Industry section.
How was this field born and how is it evolving?
What are the main business models?
What are the innovation dynamics in this field? (inputs/outputs, timing of innovation/ disruptive or incremental innovation?)
How does knowledge flow in this field?
Is this field replicating models from other fields?
How many companies?
- Diagnostic Kit Manufacturers:
- Diagnostic laboratories:
- Hospital Labs:
- References labs:
- CLIA labs:
- CLIA labs offering ASR-based diagnostics:
"In 2002, nine companies accounted for 78% of the US diagnostics market" - The Value of Diagnostics pg. 53, referencing Quirk WR. The in-vitro diagnostics industry: overview and emerging opportunities. Toronto, Canada: RBC Capital Markets, 2003.
- Roche: 22%
- Abbott Labs: 11%
- J&J: 9%
- Gen-Probe: 8%
- Beckman C: 6%
- Becton D: 6%
- Dade Behring: 6%
- Bayer: 5%
- BioMerieux: 5%
- other: 22%